← Eichor
Study identifier: NCT06008288 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

Condition: KRAS P.G12C · Pancreatic Cancer · Solid Tumor  ·  Sponsor: Allist Pharmaceuticals, Inc.

PhasePhase 2
Planned participants88
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Patients with other advanced solid tumors (excluding NSCLC and CRC) who have progressed after prior systemic therapy or are intolerant and lack satisfactory alternative treatment options, aiming to evaluate the efficacy and safety of Glecirasib in these patients.

This description comes directly from the study's public registry record.

Talk to the study team

Shanghai Allist Pharmaceuticals Co., Ltd  ·  86-21-80423288  ·  zhenhua.gong@allist.com.cn

Always discuss trial participation with your own doctor first.

Locations (31)

Anhui Provincial Cancer HospitalHefei, Anhui, ChinaRecruiting
Beijing Cancer HospitalBeijing, Beijing Municipality, ChinaRecruiting
Peking Union Medical College HospitalBeijing, Beijing Municipality, ChinaRecruiting
Beijing Tsinghua Changgung HospitalBeijing, Beijing Municipality, ChinaRecruiting
Cancer Hospital Chinese Academy of Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting
Fujian Cancer HospitalFuzhou, Fujian, ChinaRecruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaRecruiting
Sun Yat-Sen University Cancer CenterGuangzhou, Guangdong, ChinaRecruiting
The First Affiliated Hospital of Sun, Yat-sen UniversityGuangzhou, Guangdong, ChinaRecruiting
Guangxi Medical University Cancer HospitalNanning, Guangxi, ChinaRecruiting
Harbin Medical University Cancer HospitalHarbin, Heilongjiang, ChinaRecruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaRecruiting

+ 19 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06008288